SPOTLIGHT -
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
From the Pages of Psychiatric Times: April 2024
What Will the Future of Alzheimer Disease Treatment Look Like?
Assessing and Treating Insomnia in Older Adults
Diagnosis and Treatment of Depressive and Memory Problems in Older Adults
Treatment-Resistant Geriatric Depression: Augmenting or Switching an Antidepressant
FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review